Quest Diagnostics vs Koninklijke Philips

Quest Diagnostics (DGX), health care, and Koninklijke Philips (PHG), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Koninklijke Philips is worth $29.2B on the stock market and Quest Diagnostics $28.2B: Koninklijke Philips is valued at 4% more. Quest Diagnostics trades at 25.5 times earnings and Koninklijke Philips at 26.0; operating margins in their latest fiscal years were 14.1% and 7.98%. Over the past year Quest Diagnostics's share price has moved +41.5% and Koninklijke Philips's +9.64%.

Key facts

Quest Diagnostics market value
$28.2B
Koninklijke Philips market value
$29.2B
Quest Diagnostics P/E
25.5
Koninklijke Philips P/E
26.0
Quest Diagnostics revenue
$11BFY to 2025-12-31
Koninklijke Philips revenue
$19.8BFY to 2025-12-31
Superinvestors holding both
1

Market values as of .

Quest Diagnostics vs Koninklijke Philips: every measure side by side
Measure Quest Diagnostics Koninklijke Philips
SectorHealth CareHealth Care
Country United States Netherlands
Fiscal year ends2025-12-312025-12-31
Size
Market cap$28.2Blower$29.2Bhigher
Revenue$11Blower$19.8Bhigher
Earnings$992Mlower$993Mhigher
Employees60,000lower63,909higher
Total assets$16.2Blower$29.9Bhigher
Valuation
P/E25.5lower26.0higher
P/S2.6higher1.5lower
P/B3.7—
Dividend yield1.29%—
Profitability
Operating margin14.1%higher7.98%lower
Balance sheet
Net assets$7.2Blower$12.2Bhigher
Total liabilities$8.9Blower$17.7Bhigher
Total debt$5.7Blower$9Bhigher
Cash on hand$420Mlower$3.1Bhigher
Price change
Today-2.23%lower-0.83%higher
1 year+41.5%higher+9.64%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (1)

Quest Diagnostics only (2)

Koninklijke Philips only (3)

Percentages are each holding's share of that investor's reported portfolio (under "Both": Quest Diagnostics / Koninklijke Philips). Who owns DGX · Who owns PHG

Further comparisons

Learn

Questions and answers

Which is bigger, Quest Diagnostics or Koninklijke Philips?

By market value, Koninklijke Philips is the larger: $29.2B against $28.2B for Quest Diagnostics. By revenue in its latest fiscal year, Koninklijke Philips is the larger: $19.8B against $11B for Quest Diagnostics.

Which has the higher P/E ratio?

Koninklijke Philips: 26.0, against 25.5 for Quest Diagnostics. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Quest Diagnostics: 14.1%, against 7.98% for Koninklijke Philips. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has more debt?

Koninklijke Philips: $9B, against $5.7B for Quest Diagnostics. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Quest Diagnostics and Koninklijke Philips?

In their latest 13F filings, Pat English holds both.

Cite this page

Funkfolio, “Quest Diagnostics vs Koninklijke Philips”, data as of 18 November 2026. https://funkfolio.com/compare/dgx-vs-phg

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.